Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height

Northwest Biotherapeutics

Northwest Biotherapeutics reported $-0.01 in EPS Earnings Per Share for its fiscal quarter ending in March of 2023.


Fiscal Calendar Actual Date
FY2023Q1 Mar/2023 -0.01 -0.01 May/18 2023
FY20 Q3 Sep/2022 -0.03 0.05 Nov/17 2022
FY2022Q2 Jun/2022 -0.03 0.01 Aug/15 2022
FY2022Q1 Mar/2022 -0.01 -0.45 May/23 2022
FY2021Q4 Dec/2021 0.14 -0.07 Mar/02 2022
FY2021Q3 Sep/2021 0.05 -0.53 Nov/18 2021
FY2021Q2 Jun/2021 0.01 -1.40 Aug/16 2021
FY2020Q4 Dec/2020 -0.07 Jan/15 2021
FY2014Q1 Mar/2014 -0.88 May/15 2014
FY2013Q4 Dec/2013 -0.40 Dec/31 2013
FY2013Q3 Sep/2013 -0.65 Sep/30 2013

Eps Change
Agenus AGEN:US USD -0.22 0.02
AstraZeneca AZN:LN USD 1.92 0.54
Bristol-Myers Squibb BMY:US USD 2.05 0.23
Celldex Therapeutics CLDX:US USD -0.62 0.06
CTI Biopharma CTIC:US USD -0.1 0.04
Eisai 4523:JP JPY 56.92 26.78
Infinity Pharmaceuticals INFI:US USD -0.12 0.01
Merck & Co MRK:US USD 1.4 0.22
Mirati Therapeutics MRTX:US USD -3.18 0.33
Northwest Biotherapeutics NWBO:US USD -0.01 0.02
Pfizer PFE:US USD 1.23 0.09
Plus Therapeutics, Inc. CYTX:US USD -0.14 0.08
Roche Holding ROG:VX CHF 8.54 3.22